Coronavirus Test Kits Market in North America 2024-2028- Product Image

New

Coronavirus Test Kits Market in North America 2024-2028

Report
158 Pages
September 2024
Region: North America
TechNavio
ID: 5027178

The coronavirus test kits market in north america is forecasted to grow by USD -1419 million during 2023-2028, accelerating at a CAGR of -71.7% during the forecast period. The report on the coronavirus test kits market in north america provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of COVID-19 testing with routine healthcare check-ups, growing demand of coronavirus test kits due to international travel testing requirements, and government initiatives to boost sales of coronavirus test kits.

The coronavirus test kits market in north america is segmented as below:

By End-user

Government
Non-government

By Type

Rapid test kit
RT-PCR
Others

By Geographical Landscape

North America

This study identifies the launch of new COVID-19 test kits as one of the prime reasons driving the coronavirus test kits market in north america growth during the next few years. Also, rise of digital health solution and advancements in technology to develop rapid and accurate COVID-19 test kits will lead to sizable demand in the market.

The report on the coronavirus test kits market in north america covers the following areas:

Coronavirus test kits market in north america sizing
Coronavirus test kits market in north america forecast
Coronavirus test kits market in north america industry analysis

A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in north america vendors that include Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc, bioMerieux SA, Cellex Inc., Co Diagnostics Inc, Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN N.V., QuidelOrtho Corp., RayBiotech Life Inc., Robert Bosch GmbH, Sherlock Biosciences, Talis Biomedical Corp, and Thermo Fisher Scientific Inc. Also, the coronavirus test kits market in north america analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview

Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem

Parent Market
Data Table on - Parent Market

2.2 Market characteristics

Market characteristics analysis

2.3 Value chain analysis

Value Chain Analysis

3 Market Sizing

3.1 Market definition

Offerings of companies included in the market definition

3.2 Market segment analysis

Market segments

3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Chart on North America: Year-over-year growth 2023-2028 (%)
Data Table on Regional - Market size and forecast 2023-2028 ($ million)

4 Historic Market Size

4.1 Coronavirus Test Kits Market in North America 2018 - 2022

Historic Market Size - Data Table on Coronavirus Test Kits Market in North America 2018 - 2022 ($ million)

4.2 End-user segment analysis 2018 - 2022

Historic Market Size - End-user Segment 2018 - 2022 ($ million)

4.3 Type segment analysis 2018 - 2022

Historic Market Size - Type Segment 2018 - 2022 ($ million)

4.4 Geography segment analysis 2018 - 2022

Historic Market Size - Geography Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary

Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers

Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers

Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants

Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes

Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry

Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition

Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments

Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)

6.2 Comparison by End-user

Chart on Comparison by End-user
Data Table on Comparison by End-user

6.3 Government - Market size and forecast 2023-2028

Chart on Government - Market size and forecast 2023-2028 ($ million)
Data Table on Government - Market size and forecast 2023-2028 ($ million)
Chart on Government - Year-over-year growth 2023-2028 (%)
Data Table on Government - Year-over-year growth 2023-2028 (%)

6.4 Non-government - Market size and forecast 2023-2028

Chart on Non-government - Market size and forecast 2023-2028 ($ million)
Data Table on Non-government - Market size and forecast 2023-2028 ($ million)
Chart on Non-government - Year-over-year growth 2023-2028 (%)
Data Table on Non-government - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by End-user

Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

7.1 Market segments

Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)

7.2 Comparison by Type

Chart on Comparison by Type
Data Table on Comparison by Type

7.3 Rapid test kit - Market size and forecast 2023-2028

Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Chart on Rapid test kit - Year-over-year growth 2023-2028 (%)
Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%)

7.4 RT-PCR - Market size and forecast 2023-2028

Chart on RT-PCR - Market size and forecast 2023-2028 ($ million)
Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million)
Chart on RT-PCR - Year-over-year growth 2023-2028 (%)
Data Table on RT-PCR - Year-over-year growth 2023-2028 (%)

7.5 Others - Market size and forecast 2023-2028

Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Type

Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation

Chart on Market share By Geographical Landscape - 2023-2028 (%)
Data Table on Market share By Geographical Landscape - 2023-2028 (%)

9.2 Geographic comparison

Chart on Geographic comparison
Data Table on Geographic comparison

9.3 US - Market size and forecast 2023-2028

Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)

9.4 Canada - Market size and forecast 2023-2028

Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.5 Mexico - Market size and forecast 2023-2028

Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Chart on Mexico - Year-over-year growth 2023-2028 (%)
Data Table on Mexico - Year-over-year growth 2023-2028 (%)

9.6 Market opportunity By Geographical Landscape

Market opportunity By Geographical Landscape ($ million)
Data Table on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges

Impact of drivers and challenges in 2023 and 2028

10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape

Overview on criticality of inputs and factors of differentiation

11.3 Landscape disruption

Overview on factors of disruption

11.4 Industry risks

Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled

Companies covered

12.2 Market positioning of companies

Matrix on companies position and classification

12.3 Abbott Laboratories

Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus

12.4 Advaite Inc.

Advaite Inc. - Overview
Advaite Inc. - Product / Service
Advaite Inc. - Key offerings

12.5 Becton Dickinson and Co.

Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus

12.6 Biomedomics Inc

Biomedomics Inc - Overview
Biomedomics Inc - Product / Service
Biomedomics Inc - Key offerings

12.7 bioMerieux SA

bioMerieux SA - Overview
bioMerieux SA - Product / Service
bioMerieux SA - Key offerings

12.8 Cellex Inc.

Cellex Inc. - Overview
Cellex Inc. - Product / Service
Cellex Inc. - Key offerings

12.9 Co Diagnostics Inc

Co Diagnostics Inc - Overview
Co Diagnostics Inc - Product / Service
Co Diagnostics Inc - Key offerings

12.10 Cue Health Inc.

Cue Health Inc. - Overview
Cue Health Inc. - Product / Service
Cue Health Inc. - Key offerings

12.11 Danaher Corp.

Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus

12.12 DiaSorin SpA

DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key news
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus

12.13 F. Hoffmann La Roche Ltd.

F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus

12.14 Hologic Inc.

Hologic Inc. - Overview
Hologic Inc. - Business segments
Hologic Inc. - Key news
Hologic Inc. - Key offerings
Hologic Inc. - Segment focus

12.15 Laboratory Corp. of America Holdings

Laboratory Corp. of America Holdings - Overview
Laboratory Corp. of America Holdings - Business segments
Laboratory Corp. of America Holdings - Key news
Laboratory Corp. of America Holdings - Key offerings
Laboratory Corp. of America Holdings - Segment focus

12.16 QIAGEN N.V.

QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key news
QIAGEN N.V. - Key offerings

12.17 Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist

Inclusions checklist
Exclusions checklist

13.3 Currency conversion rates for US$

Currency conversion rates for US$

13.4 Research methodology

Research methodology

13.5 Data procurement

Information sources

13.6 Data validation

Data validation

13.7 Validation techniques employed for market sizing

Validation techniques employed for market sizing

13.8 Data synthesis

Data synthesis

13.9 360 degree market analysis

360 degree market analysis

13.10 List of abbreviations

List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on North America: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 20: Historic Market Size - Data Table on Coronavirus Test Kits Market in North America 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Five forces analysis - Comparison between 2023 and 2028
Exhibits 25: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 30: Chart on Market condition - Five forces 2023 and 2028
Exhibits 31: Chart on End-user - Market share 2023-2028 (%)
Exhibits 32: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 33: Chart on Comparison by End-user
Exhibits 34: Data Table on Comparison by End-user
Exhibits 35: Chart on Government - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Government - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Government - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Government - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Non-government - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Non-government - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Non-government - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Non-government - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by End-user ($ million)
Exhibits 44: Data Table on Market opportunity by End-user ($ million)
Exhibits 45: Chart on Type - Market share 2023-2028 (%)
Exhibits 46: Data Table on Type - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by Type
Exhibits 48: Data Table on Comparison by Type
Exhibits 49: Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Rapid test kit - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on RT-PCR - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on RT-PCR - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on RT-PCR - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 61: Market opportunity by Type ($ million)
Exhibits 62: Data Table on Market opportunity by Type ($ million)
Exhibits 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 64: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 65: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 66: Chart on Geographic comparison
Exhibits 67: Data Table on Geographic comparison
Exhibits 68: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 75: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 76: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 79: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 80: Market opportunity By Geographical Landscape ($ million)
Exhibits 81: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits 82: Impact of drivers and challenges in 2023 and 2028
Exhibits 83: Overview on criticality of inputs and factors of differentiation
Exhibits 84: Overview on factors of disruption
Exhibits 85: Impact of key risks on business
Exhibits 86: Companies covered
Exhibits 87: Matrix on companies position and classification
Exhibits 88: Abbott Laboratories - Overview
Exhibits 89: Abbott Laboratories - Business segments
Exhibits 90: Abbott Laboratories - Key news
Exhibits 91: Abbott Laboratories - Key offerings
Exhibits 92: Abbott Laboratories - Segment focus
Exhibits 93: Advaite Inc. - Overview
Exhibits 94: Advaite Inc. - Product / Service
Exhibits 95: Advaite Inc. - Key offerings
Exhibits 96: Becton Dickinson and Co. - Overview
Exhibits 97: Becton Dickinson and Co. - Business segments
Exhibits 98: Becton Dickinson and Co. - Key news
Exhibits 99: Becton Dickinson and Co. - Key offerings
Exhibits 100: Becton Dickinson and Co. - Segment focus
Exhibits 101: Biomedomics Inc - Overview
Exhibits 102: Biomedomics Inc - Product / Service
Exhibits 103: Biomedomics Inc - Key offerings
Exhibits 104: bioMerieux SA - Overview
Exhibits 105: bioMerieux SA - Product / Service
Exhibits 106: bioMerieux SA - Key offerings
Exhibits 107: Cellex Inc. - Overview
Exhibits 108: Cellex Inc. - Product / Service
Exhibits 109: Cellex Inc. - Key offerings
Exhibits 110: Co Diagnostics Inc - Overview
Exhibits 111: Co Diagnostics Inc - Product / Service
Exhibits 112: Co Diagnostics Inc - Key offerings
Exhibits 113: Cue Health Inc. - Overview
Exhibits 114: Cue Health Inc. - Product / Service
Exhibits 115: Cue Health Inc. - Key offerings
Exhibits 116: Danaher Corp. - Overview
Exhibits 117: Danaher Corp. - Business segments
Exhibits 118: Danaher Corp. - Key news
Exhibits 119: Danaher Corp. - Key offerings
Exhibits 120: Danaher Corp. - Segment focus
Exhibits 121: DiaSorin SpA - Overview
Exhibits 122: DiaSorin SpA - Business segments
Exhibits 123: DiaSorin SpA - Key news
Exhibits 124: DiaSorin SpA - Key offerings
Exhibits 125: DiaSorin SpA - Segment focus
Exhibits 126: F. Hoffmann La Roche Ltd. - Overview
Exhibits 127: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 128: F. Hoffmann La Roche Ltd. - Key news
Exhibits 129: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 130: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 131: Hologic Inc. - Overview
Exhibits 132: Hologic Inc. - Business segments
Exhibits 133: Hologic Inc. - Key news
Exhibits 134: Hologic Inc. - Key offerings
Exhibits 135: Hologic Inc. - Segment focus
Exhibits 136: Laboratory Corp. of America Holdings - Overview
Exhibits 137: Laboratory Corp. of America Holdings - Business segments
Exhibits 138: Laboratory Corp. of America Holdings - Key news
Exhibits 139: Laboratory Corp. of America Holdings - Key offerings
Exhibits 140: Laboratory Corp. of America Holdings - Segment focus
Exhibits 141: QIAGEN N.V. - Overview
Exhibits 142: QIAGEN N.V. - Product / Service
Exhibits 143: QIAGEN N.V. - Key news
Exhibits 144: QIAGEN N.V. - Key offerings
Exhibits 145: Thermo Fisher Scientific Inc. - Overview
Exhibits 146: Thermo Fisher Scientific Inc. - Business segments
Exhibits 147: Thermo Fisher Scientific Inc. - Key news
Exhibits 148: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 149: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 150: Inclusions checklist
Exhibits 151: Exclusions checklist
Exhibits 152: Currency conversion rates for US$
Exhibits 153: Research methodology
Exhibits 154: Information sources
Exhibits 155: Data validation
Exhibits 156: Validation techniques employed for market sizing
Exhibits 157: Data synthesis
Exhibits 158: 360 degree market analysis
Exhibits 159: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the coronavirus test kits market in North America: Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc, bioMerieux SA, Cellex Inc., Co Diagnostics Inc, Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN N.V., QuidelOrtho Corp., RayBiotech Life Inc., Robert Bosch GmbH, Sherlock Biosciences, Talis Biomedical Corp, and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is launch of new COVID-19 test kits."

According to the report, one of the major drivers for this market is the integration of COVID-19 testing with routine healthcare check-ups.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Advaite Inc.
Becton Dickinson and Co.
Biomedomics Inc
bioMerieux SA
Cellex Inc.
Co Diagnostics Inc
Cue Health Inc.
Danaher Corp.
DiaSorin SpA
F. Hoffmann La Roche Ltd.
Hologic Inc.
Laboratory Corp. of America Holdings
Mammoth Biosciences Inc.
MyBioSource Inc.
QIAGEN N.V.
QuidelOrtho Corp.
RayBiotech Life Inc.
Robert Bosch GmbH
Sherlock Biosciences
Talis Biomedical Corp
Thermo Fisher Scientific Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2443EUR$2,500USD£2,039GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3908EUR$4,000USD£3,263GBP

The coronavirus test kits market in north america is segmented as below:

By End-user

By Type

By Geographical Landscape

The report on the coronavirus test kits market in north america covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Coronavirus Test Kits Market 2024-2028

Coronavirus Test Kits Market by Product Type, Specimen Type, End-User - Global Forecast 2025-2030

COVID-19 Detection Kits Market Size, Share & Trends Analysis Report By Product (RT-PCR Assay Kits), By Sample Type (Nasopharyngeal), By Mode (Centralized Testing), By End-use (Laboratories), By Region, And Segment Forecasts, 2024 - 2030

2024-2028 Global Coronavirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

Hepatitis B and C Diagnostics Market 2024-2028

About the POC COVID Diagnostics Market